Skip to main content

and
  1. Article

    Open Access

    A novel CAR-T cell product targeting CD74 is an effective therapeutic approach in preclinical mantle cell lymphoma models

    Mantle cell lymphoma (MCL) is a rare B-cell non-Hodgkin lymphoma subtype which remains incurable despite multimodal approach including chemoimmunotherapy followed by stem cell transplant, targeted approaches s...

    Wing Keung Chan, Jessica Williams, Kinnari Sorathia in Experimental Hematology & Oncology (2023)

  2. Article

    Open Access

    A sumoylation program is essential for maintaining the mitotic fidelity in proliferating mantle cell lymphoma cells

    Mantle cell lymphoma (MCL) is a rare, highly heterogeneous type of B-cell non-Hodgkin’s lymphoma. The sumoylation pathway is known to be upregulated in many cancers including lymphoid malignancies. However, li...

    Walter Hanel, Pushpa Lata, Youssef Youssef, Ha Tran in Experimental Hematology & Oncology (2022)

  3. Article

    Open Access

    The effects of β-glucan on human immune and cancer cells

    Non-prescriptional use of medicinal herbs among cancer patients is common around the world. The alleged anti-cancer effects of most herbal extracts are mainly based on studies derived from in vitro or in vivo ani...

    Godfrey Chi-Fung Chan, Wing Keung Chan in Journal of Hematology & Oncology (2009)

  4. Article

    Open Access

    Ganoderma lucidum polysaccharides can induce human monocytic leukemia cells into dendritic cells with immuno-stimulatory function

    Previous studies demonstrated Ganoderma lucidum polysaccharides (GL-PS), a form of bioactive β-glucan can stimulate the maturation of monocyte-derived dendritic cells (DC). The question of how leukemic cells espe...

    Wing Keung Chan, Christopher Ching Hang Cheung in Journal of Hematology & Oncology (2008)